Phenixfin Free Cash Flow vs End Period Cash Flow Analysis

PFX Stock

USD 47.23 0.60 1.29%

Phenixfin financial indicator trend analysis is much more than just breaking down Phenixfin prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phenixfin is a good investment. Please check the relationship between Phenixfin Free Cash Flow and its End Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.

Free Cash Flow vs End Period Cash Flow

Free Cash Flow vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phenixfin Free Cash Flow account and End Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.

The correlation between Phenixfin's Free Cash Flow and End Period Cash Flow is 0.65. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Phenixfin, assuming nothing else is changed. The correlation between historical values of Phenixfin's Free Cash Flow and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Phenixfin are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Free Cash Flow i.e., Phenixfin's Free Cash Flow and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.65

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

End Period Cash Flow

Most indicators from Phenixfin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phenixfin current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.At this time, Phenixfin's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 4.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.3 M in 2024.

Phenixfin fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Net Debt	Cash	Non Current Assets Total	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Intangible Assets	Total Stockholder Equity	Current Deferred Revenue	Retained Earnings	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Common Stock	Other Current Liab	Property Plant And Equipment Net	Accounts Payable
Total Assets		1.0	0.65	1.0	0.89	0.17	1.0	1.0	1.0	1.0	0.94	0.97	-0.08	-0.25	0.46	0.09	0.16	-0.16	-0.17	-0.08	-0.27	-0.63	-0.07	0.1	0.39	-0.14
Short Long Term Debt Total	1.0		0.64	1.0	0.88	0.14	1.0	1.0	1.0	1.0	0.95	0.97	-0.11	-0.26	0.46	0.08	0.15	-0.16	-0.2	-0.11	-0.3	-0.63	-0.1	0.11	0.37	-0.15
Total Current Liabilities	0.65	0.64		0.64	0.58	0.42	0.63	0.63	0.63	0.64	0.65	0.65	0.3	-0.27	0.23	0.06	0.32	-0.06	0.43	0.21	0.1	-0.24	0.21	-0.04	0.47	0.65
Net Debt	1.0	1.0	0.64		0.88	0.14	1.0	1.0	1.0	1.0	0.95	0.97	-0.11	-0.26	0.46	0.08	0.14	-0.17	-0.2	-0.11	-0.3	-0.63	-0.1	0.11	0.38	-0.15
Cash	0.89	0.88	0.58	0.88		0.24	0.88	0.88	0.89	0.88	0.88	0.9	-0.02	-0.36	0.31	0.05	0.36	0.32	-0.16	-0.09	-0.08	-0.58	0.12	-0.18	0.12	-0.17
Non Current Assets Total	0.17	0.14	0.42	0.14	0.24		0.12	0.11	0.12	0.14	0.01	0.2	0.95	0.36	0.09	0.43	0.48	0.27	0.77	0.87	0.88	-0.27	0.85	-0.53	0.57	0.37
Good Will	1.0	1.0	0.63	1.0	0.88	0.12		1.0	1.0	1.0	0.95	0.97	-0.13	-0.28	0.47	0.07	0.14	-0.17	-0.21	-0.13	-0.32	-0.62	-0.12	0.12	0.37	-0.16
Common Stock Total Equity	1.0	1.0	0.63	1.0	0.88	0.11	1.0		1.0	1.0	0.95	0.97	-0.13	-0.27	0.46	0.07	0.13	-0.17	-0.21	-0.13	-0.32	-0.62	-0.12	0.13	0.36	-0.16
Common Stock Shares Outstanding	1.0	1.0	0.63	1.0	0.89	0.12	1.0	1.0		1.0	0.95	0.97	-0.13	-0.28	0.45	0.06	0.14	-0.16	-0.21	-0.13	-0.31	-0.61	-0.11	0.12	0.36	-0.16
Total Liab	1.0	1.0	0.64	1.0	0.88	0.14	1.0	1.0	1.0		0.95	0.97	-0.1	-0.26	0.46	0.08	0.15	-0.16	-0.19	-0.1	-0.29	-0.63	-0.09	0.11	0.38	-0.15
Total Current Assets	0.94	0.95	0.65	0.95	0.88	0.01	0.95	0.95	0.95	0.95		0.94	-0.22	-0.47	0.36	-0.16	0.22	-0.07	-0.28	-0.25	-0.37	-0.5	-0.16	0.13	0.26	-0.12
Intangible Assets	0.97	0.97	0.65	0.97	0.9	0.2	0.97	0.97	0.97	0.97	0.94		-0.04	-0.35	0.48	0.05	0.3	-0.08	-0.18	-0.08	-0.23	-0.68	-0.01	0.04	0.41	-0.14
Total Stockholder Equity	-0.08	-0.11	0.3	-0.11	-0.02	0.95	-0.13	-0.13	-0.13	-0.1	-0.22	-0.04		0.4	0.04	0.4	0.45	0.21	0.85	0.93	0.9	-0.16	0.83	-0.47	0.59	0.44
Current Deferred Revenue	-0.25	-0.26	-0.27	-0.26	-0.36	0.36	-0.28	-0.27	-0.28	-0.26	-0.47	-0.35	0.4		-0.12	0.4	-0.56	-0.19	0.46	0.55	0.41	0.1	0.3	-0.15	0.1	0.06
Retained Earnings	0.46	0.46	0.23	0.46	0.31	0.09	0.47	0.46	0.45	0.46	0.36	0.48	0.04	-0.12		0.15	0.25	-0.29	-0.12	0.06	-0.2	-0.82	0.0	0.12	0.59	-0.19
Non Currrent Assets Other	0.09	0.08	0.06	0.08	0.05	0.43	0.07	0.07	0.06	0.08	-0.16	0.05	0.4	0.4	0.15		-0.07	-0.03	0.43	0.49	0.29	-0.24	0.12	0.08	0.25	0.04
Other Assets	0.16	0.15	0.32	0.14	0.36	0.48	0.14	0.13	0.14	0.15	0.22	0.3	0.45	-0.56	0.25	-0.07		0.48	0.12	0.23	0.42	-0.38	0.54	-0.45	0.35	0.08
Cash And Short Term Investments	-0.16	-0.16	-0.06	-0.17	0.32	0.27	-0.17	-0.17	-0.16	-0.16	-0.07	-0.08	0.21	-0.19	-0.29	-0.03	0.48		0.09	0.07	0.47	0.05	0.49	-0.62	-0.47	-0.02
Net Receivables	-0.17	-0.2	0.43	-0.2	-0.16	0.77	-0.21	-0.21	-0.21	-0.19	-0.28	-0.18	0.85	0.46	-0.12	0.43	0.12	0.09		0.82	0.74	0.13	0.61	-0.26	0.42	0.77
Short Term Investments	-0.08	-0.11	0.21	-0.11	-0.09	0.87	-0.13	-0.13	-0.13	-0.1	-0.25	-0.08	0.93	0.55	0.06	0.49	0.23	0.07	0.82		0.8	-0.19	0.66	-0.23	0.57	0.38
Non Current Liabilities Total	-0.27	-0.3	0.1	-0.3	-0.08	0.88	-0.32	-0.32	-0.31	-0.29	-0.37	-0.23	0.9	0.41	-0.2	0.29	0.42	0.47	0.74	0.8		0.07	0.89	-0.65	0.24	0.38
Other Stockholder Equity	-0.63	-0.63	-0.24	-0.63	-0.58	-0.27	-0.62	-0.62	-0.61	-0.63	-0.5	-0.68	-0.16	0.1	-0.82	-0.24	-0.38	0.05	0.13	-0.19	0.07		-0.14	0.03	-0.54	0.35
Common Stock	-0.07	-0.1	0.21	-0.1	0.12	0.85	-0.12	-0.12	-0.11	-0.09	-0.16	-0.01	0.83	0.3	0.0	0.12	0.54	0.49	0.61	0.66	0.89	-0.14		-0.87	0.33	0.3
Other Current Liab	0.1	0.11	-0.04	0.11	-0.18	-0.53	0.12	0.13	0.12	0.11	0.13	0.04	-0.47	-0.15	0.12	0.08	-0.45	-0.62	-0.26	-0.23	-0.65	0.03	-0.87		0.04	-0.1
Property Plant And Equipment Net	0.39	0.37	0.47	0.38	0.12	0.57	0.37	0.36	0.36	0.38	0.26	0.41	0.59	0.1	0.59	0.25	0.35	-0.47	0.42	0.57	0.24	-0.54	0.33	0.04		0.2
Accounts Payable	-0.14	-0.15	0.65	-0.15	-0.17	0.37	-0.16	-0.16	-0.16	-0.15	-0.12	-0.14	0.44	0.06	-0.19	0.04	0.08	-0.02	0.77	0.38	0.38	0.35	0.3	-0.1	0.2

Click cells to compare fundamentals

Phenixfin Account Relationship Matchups

Phenixfin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	306.1M	225.1M	218.9M	239.7M	215.7M	204.9M
Short Long Term Debt Total	151.0M	78.0M	78.5M	84.5M	76.1M	72.3M
Total Current Liabilities	4.5M	3.4M	19.2M	(156.4K)	(140.7K)	(133.7K)
Net Debt	94.4M	8.6M	55.8M	78.5M	70.7M	67.2M
Cash	56.5M	69.4M	22.8M	6.0M	5.4M	5.1M
Non Current Assets Total	248.8M	153.0M	194.2M	228.0M	205.2M	194.9M
Liabilities And Stockholders Equity	306.1M	225.1M	218.9M	239.7M	215.7M	204.9M
Total Liab	155.5M	81.4M	98.0M	93.0M	83.7M	79.5M
Total Current Assets	57.3M	72.1M	24.7M	11.7M	10.5M	10.0M
Accumulated Other Comprehensive Income	150.6M	143.7M	120.8M	146.7M	168.7M	177.1M
Total Stockholder Equity	150.6M	143.7M	120.8M	146.7M	132.0M	125.4M
Current Deferred Revenue	(76.9M)	(77.4M)	(78.0M)	421.7M	379.5M	398.5M
Retained Earnings	(521.8M)	(545.2M)	(554.6M)	(548.1M)	(493.3M)	(468.6M)
Non Currrent Assets Other	(304.0M)	788.2K	729.5K	1.1M	974.1K	1.0M
Other Assets	2.1M	1.4M	(1.4M)	(6.9B)	(6.3B)	(5.9B)
Cash And Short Term Investments	56.5M	69.4M	22.8M	6.0M	6.9M	6.5M
Net Receivables	743.6K	2.6M	1.4M	5.5M	5.0M	5.9M
Non Current Liabilities Total	151.0M	78.0M	78.9M	85.2M	76.7M	72.9M
Other Stockholder Equity	672.4M	688.9M	675.4M	694.8M	799.0M	623.2M
Common Stock	2.7K	2.5K	2.1K	2.1K	1.9K	1.8K
Other Current Liab	(76.1M)	1.9M	578.0K	(7.2M)	(8.3M)	(8.7M)
Accounts Payable	2.1M	1.4M	18.6M	7.2M	6.5M	8.5M
Short Term Debt	74.0M	77.4M	78.0M	84.3M	75.8M	72.0M
Other Liab	103.6K	10.5K	34.0	327.9K	295.1K	240.8K
Net Tangible Assets	216.4M	150.6M	143.7M	120.8M	108.8M	188.4M
Net Invested Capital	301.6M	221.1M	198.8M	231.0M	207.9M	354.2M
Long Term Investments	246.7M	151.6M	193.0M	226.5M	203.8M	309.4M
Capital Stock	2.7K	2.5K	2.1K	2.1K	1.9K	1.8K
Other Current Assets	0.0	292.0K	1.4M	639.7K	735.6K	772.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Phenixfin Stock Analysis

When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phenixfin Free Cash Flow vs End Period Cash Flow Analysis

Free Cash Flow vs End Period Cash Flow

Free Cash Flow vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Free Cash Flow

End Period Cash Flow

Phenixfin fundamental ratios Correlations

Phenixfin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Phenixfin fundamental ratios Accounts

Also Currently Popular

Additional Tools for Phenixfin Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Total Assets
Net Debt	+ 1.0	Total Assets
Good Will	+ 1.0	Total Assets
Common Stock Total Equity	+ 1.0	Total Assets
Common Stock Shares Outstanding	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets

Other Current Liab	- 0.87	Common Stock
Other Stockholder Equity	- 0.82	Retained Earnings
Other Stockholder Equity	- 0.68	Intangible Assets
Other Current Liab	- 0.65	Non Current Liabilities Total
Other Stockholder Equity	- 0.63	Total Liab
Other Stockholder Equity	- 0.63	Net Debt